Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Sysco Q2 Profit Down - Quick Facts

RELATED NEWS
Trade SYY now with 

Sysco Corp. (SYY: Quote) reported that its second-quarter net earnings declined to $250.11 million or $0.43 per share, from $258.17 million or $0.44 per share in the same quarter last year. However, Non-GAAP net income rose to $0.46 per share from $0.45 per share in the year ago quarter.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.44 per share for the quarter. Analysts' estimates typically exclude special items.

Sales for the quarter rose to $10.24 billion from $9.38 billion in the prior year quarter. Nine analysts had consensus revenue estimate of $10.04 billion for the quarter.

Click here to receive FREE breaking news email alerts for Sysco Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. said Monday that its fourth quarter profit rose 13% from last year, driven by strong sales of its iPhones and Mac computers. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly sales. At the same time, the company gave an upbeat revenue forecast for the current quarter, which includes the all important holiday season. Stocks moved notably higher over the course of the trading day on Monday, extending the strong upward move seen last Friday. The gains on the day continued the recent recovery by the markets, with the Nasdaq and the S&P 500 closing higher for the third consecutive session. While Republicans have largely tried to frame the upcoming midterm elections as a referendum on President Barack Obama, Sen. Ted Cruz, R-Tex., has joined the few offering guidance on what the GOP will do if it manages to retake control of the Senate.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.